NEW YORK, 2013-10-04 14:30 CEST (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of Daniel P. Regan to the Company's Board of Directors.
Daniel P. Regan, 49, joins the Keryx Board of Directors with broad pharmaceutical leadership experience across the spectrum of global commercialization, sales and marketing of novel therapies for the treatment of patients with chronic kidney disease.
Help employers find you! Check out all the jobs and post your resume.
